Cargando…

S69. CLINICAL HIGH RISK STATE: STRATIFICATION BASED ON CLINICAL PROFILE AND REDOX STATUS

BACKGROUND: The Clinical High Risk state (CHR) concept was implemented to promote the early detection of young help-seeking patients with higher risk of psychotic transition. This category is based on specific clinical criteria (EPA, 2015) and require narrow frequency/duration ratings of subclinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cleusix, Martine, Khadimallah, Ines, Toffel, Elodie, Klauser, Paul, Do, Kim Q, von Plessen, Kerstin, Conus, Philippe, Solida, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Session I
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233980/ http://dx.doi.org/10.1093/schbul/sbaa031.135

Ejemplares similares

T160. HIGH-RESOLUTION WHOLE BRAIN MR SPECTROSCOPIC IMAGING IN YOUTHS AT CLINICAL HIGH RISK FOR PSYCHOSIS: A PILOT STUDY
por: Klauser, Paul, et al.
Publicado: (2020)

Redox dysregulation as a link between childhood trauma and psychopathological and neurocognitive profile in patients with early psychosis
por: Alameda, Luis, et al.
Publicado: (2018)

16.2 CHILDHOOD TRAUMA ENGAGES OXIDATIVE STRESS, HIPPOCAMPUS ALTERATIONS, AND POORER CLINICAL OUTCOME IN EARLY PSYCHOSIS PATIENTS
por: Alameda, Luis, et al.
Publicado: (2018)

S164. “AT-RISK MENTAL STATES” PROGRAM IN LAUSANNE: INFLUENCE OF RECRUITMENT STRATEGIES ON THE RATE OF FALSE POSITIVES
por: Solida, Alessandra, et al.
Publicado: (2018)

M16. PROFILING GLUTAMATE AND D-SERINE PATHWAYS IN TREATMENT RESISTANT EARLY PSYCHOSIS PATIENTS
por: Camporesi, Sara, et al.
Publicado: (2020)

10.2 REDOX DYSREGULATION, OLIGODENDROCYTES AND WHITE MATTER ALTERATIONS IN SCHIZOPHRENIA
por: Klauser, Paul, et al.
Publicado: (2018)

Brain connectivity alterations in early psychosis: from clinical to neuroimaging staging
por: Griffa, Alessandra, et al.
Publicado: (2019)

Characterization of early psychosis patients carrying a genetic vulnerability to redox dysregulation: a computational analysis of mechanism-based gene expression profile in fibroblasts
por: Giangreco, Basilio, et al.
Publicado: (2023)

Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia
por: Cuenod, Michel, et al.
Publicado: (2021)

Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia; Response to “Adaptive changes to oxidative stress in schizophrenia by Lena Palaniyappan”
por: Cuenod, Michel, et al.
Publicado: (2022)

S143. NEURAL MECHANISMS OF ROBOT-INDUCED HALLUCINATIONS IN HEALTHY PARTICIPANTS AND SYMPTOMATIC HALLUCINATIONS OF NEUROLOGICAL AND PSYCHIATRIC ORIGIN
por: Blondiaux, Eva, et al.
Publicado: (2020)

Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophrenia
por: Khadimallah, Ines, et al.
Publicado: (2021)

T52. N-ACETYL-CYSTEINE ADD-ON TREATMENT LEADS TO AN IMPROVEMENT OF FORNIX WHITE MATTER INTEGRITY IN EARLY PSYCHOSIS
por: Klauser, Paul, et al.
Publicado: (2018)

N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial
por: Klauser, Paul, et al.
Publicado: (2018)

MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients
por: Dwir, Daniella, et al.
Publicado: (2019)

S115. EVALUATION OF THE CLINICAL UTILITY OF SYMPTOM DIMENSIONS ON LONG-TERM CLINICAL AND FUNCTIONAL OUTCOMES IN FIRST EPISODE PSYCHOSIS
por: Bor, Ege, et al.
Publicado: (2020)

102. Undermining the Translational Potential of Clinical Research with Adolescents and Young Adults: Differential Enrollment in Randomized Clinical Trials During COVID-19
por: Perin, Jamie, et al.
Publicado: (2023)

S246. THE EFFECT OF INCORRECT SCALE ADMINISTRATION ON DATA QUALITY IN SCHIZOPHRENIA CLINICAL TRIALS
por: Kott, Alan, et al.
Publicado: (2020)

S64. COGNITIVE IMPAIRMENTS AND PREDICTION OF FUNCTIONAL OUTCOME IN INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS
por: Haining, Kate, et al.
Publicado: (2020)

S79. REINFORCEMENT LEARNING ABNORMALITIES IN INDIVIDUALS AT CLINICAL HIGH RISK AND IN THE FIRST EPISODE OF PSYCHOSIS
por: Datta, Raktima, et al.
Publicado: (2020)

S71. CLINICAL, BEHAVIOURAL AND NEURAL VALIDATION OF THE POSITIVE AND NEGATIVE SYMPTOM SCALE (PANSS) AMOTIVATION FACTOR
por: Kaliuzhna, Mariia, et al.
Publicado: (2020)

S159. SUBCORTICAL GRAY MATTER VOLUME IS ASSOCIATED WITH SCHIZOPHRENIA AND WITH BOTH ITS FAMILIAL AND CLINICAL RISK
por: Passiatore, Roberta, et al.
Publicado: (2020)

S147. FUNCTIONAL BRAIN CONNECTIVITY DATA IMPROVE CLINICAL OUTCOME PREDICTION IN YOUTH AT RISK FOR PSYCHOSIS
por: Collin, Guusje, et al.
Publicado: (2020)

S154. TOBACCO SMOKING AND CLINICAL HIGH RISK: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE EVIDENCE
por: De Micheli, Andrea, et al.
Publicado: (2020)

S219. SINGLE-SUBJECT PREDICTION OF FUNCTIONAL OUTCOMES ACROSS DIAGNOSTIC GROUPS USING CLINICAL DATA
por: Rosen, Marlene, et al.
Publicado: (2020)

N-Acetyl-Cysteine Supplementation Improves Functional Connectivity Within the Cingulate Cortex in Early Psychosis: A Pilot Study
por: Mullier, Emeline, et al.
Publicado: (2019)

S18. STRUCTURAL COVARIANCE PREDICTORS OF CLINICAL IMPROVEMENT AT 2-YEAR FOLLOW-UP IN FIRST-EPISODE PSYCHOSIS
por: Saiz-Masvidal, Cristina, et al.
Publicado: (2020)

S88. THE EFFECT OF SLEEP QUALITY ON ATTENUATED PSYCHOTIC SYMPTOMS IN A NON-CLINICAL SAMPLE OF YOUNG ADULTS
por: Hanna, Donncha, et al.
Publicado: (2020)

S72. MCCB COGNITIVE PROFILE IN CHINESE FIRST EPISODE SCHIZOPHRENIA PATIENTS AND SUBJECTS AT CLINICAL HIGH RISK FOR PSYCHOSIS
por: Lei, Zhao, et al.
Publicado: (2020)

S63. CLINICAL AND DEVELOPMENTAL CHARACTERISTICS OF COGNITIVE SUBGROUPS IN A TRANSDIAGNOSTIC SAMPLE OF SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDER AND BIPOLAR DISORDER
por: Bora, Emre, et al.
Publicado: (2020)

S100. INCORRECT DIAGNOSIS OF FIRST EPISODE SCHIZOPHRENIA: IMPACT OF ANXIETY AND THOUGHT DISORDER, AND THE VALUE OF A CONSULTATION CLINIC
Publicado: (2020)

S157. A MULTICENTER HARMONIZED DIFFUSION TENSOR IMAGING STUDY ON THE ASSOCIATION OF WHITE MATTER STRUCTURE AND CLINICAL FUNCTIONING
por: Seitz, Johanna, et al.
Publicado: (2020)

S175. CLINICAL OUTCOMES IN PEOPLE AT HIGH RISK FOR PSYCHOSIS RELATED TO INTERACTIONS BETWEEN POLYGENIC RISK SCORES AND CHILDHOOD ADVERSITY
por: Richter, Anja, et al.
Publicado: (2020)

S178. SHOULD SCHIZOAFFECTIVE DISORDER DEPRESSED-TYPE BE DISTINCT FROM SCHIZOPHRENIA? ANALYSIS OF GENETIC LIABILITY AND LIFETIME CLINICAL CHARACTERISTICS
por: Dennison, Charlotte, et al.
Publicado: (2020)

S203. EFFECT OF LONG-ACTING INJECTIONS OF PALIPERIDONE PALMITATE ON CLINICAL AND FUNCTIONAL OUTCOMES IN PATIENTS WITH SCHIZOPHRENIA BASED ON ILLNESS DURATION
por: Kim, Seoyoung, et al.
Publicado: (2020)

S124. EXAMINING THE CLINICAL AND NEUROCOGNITIVE CHARACTERISTICS OF FIRST-EPISODE PSYCHOSIS PATIENTS WHO WILL NEVER RELAPSE OVER 10 YEARS
Publicado: (2020)

S74. AEROBIC EXERCISE AND COGNITIVE REMEDIATION IN MULTIEPISODE SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER: PRELIMINARY RESULTS: FROM A RANDOMIZED CLINICAL TRIAL
por: Pujol, Nuria, et al.
Publicado: (2020)

S94. PREDICTION OF CANNABIS RELAPSE IN CLINICAL HIGH-RISK INDIVIDUALS AND RECENT ONSET PSYCHOSIS - PRELIMINARY RESULTS FROM THE PRONIA STUDY
por: Penzel, Nora, et al.
Publicado: (2020)

S113. TELE-PSYCHIATRIC AFTER CARE (TAC) CLINIC FROM INDIA: PATTERN OF CONTINUITY OF CARE OF PATIENTS WITH SEVERE MENTAL DISORDERS
por: Nagendrappa, Sachin, et al.
Publicado: (2020)

Redox and Immune Signaling in Schizophrenia: New Therapeutic Potential
por: Dwir, Daniella, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4435sih26759hjobio9db9c2ap